Financial Year |
March 31 2023 |
Monetary Funds |
95,532,665,000.00 |
Held-for-trading Financial Assets |
-- |
Notes Receivable |
464,126,000.00 |
Accounts Receivable |
11,184,631,000.00 |
Advances to Suppliers |
3,200,399,000.00 |
Other Receivables |
3,522,551,000.00 |
Amounts Due From Related Companies |
-- |
Interest Receivable |
-- |
Dividend Receivable |
1,004,163,000.00 |
Inventories |
9,193,197,000.00 |
Among: Consumptive Biological Assets |
-- |
Non-Current Assets Maturing Within One Year |
-- |
Other Current Assets |
1,683,174,000.00 |
Total Current Assets |
133,165,919,000.00 |
Available-for-Sale Financial Asset |
-- |
Held-to-maturity Investments |
-- |
Long-Term Account Receivable |
412,208,000.00 |
Long-term Equity Investment |
29,708,561,000.00 |
Investment Properties |
67,503,000.00 |
Fixed Assetes |
114,748,828,000.00 |
Under-construction Projects |
10,080,799,000.00 |
Construction Materials |
-- |
Disposal of Fixed Assets |
-- |
Capitalized Biological Assets |
-- |
Oil and Gas Assets |
-- |
Intangible Assets |
47,820,097,000.00 |
R&D expenses |
-- |
Goodwill |
6,084,000.00 |
Long-Term Deferred and Prepaid Expenses |
115,996,000.00 |
Deferred Income Tax Assets |
3,024,715,000.00 |
Other Non-Current Assets |
5,507,009,000.00 |
Sub-Total of Non-Current Assets |
215,255,053,000.00 |
Total Assets |
348,420,972,000.00 |
Short-Term Loans |
203,400,000.00 |
Trading Financial liabilities |
-- |
Notes Payable |
2,334,780,000.00 |
Accounts Payable |
25,522,553,000.00 |
Accounts Received In Advance |
-- |
Employee Compensation Payable |
4,720,229,000.00 |
Taxes Payable |
5,080,286,000.00 |
Interest Payable |
117,750,000.00 |
Dividend Payable |
425,331,000.00 |
Other payables |
6,249,304,000.00 |
Due to Related Companies |
-- |
Non-Current Liabilities Due Within One Year |
27,131,355,000.00 |
Other Current Liabilities |
25,862,925,000.00 |
Sub-Total of Current Liabilities |
101,557,925,000.00 |
Long-term Loans |
42,507,081,000.00 |
Bonds Payable |
12,981,316,000.00 |
Long-Term Accounts Payable |
4,140,240,000.00 |
Special Payable |
-- |
Estimatied Liabilities |
5,120,097,000.00 |
Deferred Income Tax Liabilities |
4,624,525,000.00 |
Other Non-Current Liabilities |
606,684,000.00 |
Sub-Total of Non-Current Liabilities |
72,436,373,000.00 |
Total Liabilities |
173,994,298,000.00 |
Paid-In Capital(Or Share Stock) |
13,258,663,000.00 |
Capital Surplus |
38,903,050,000.00 |
Surplus Reserve |
6,128,611,000.00 |
LESS:Treasury Stock |
-- |
Undistributed Profits |
71,802,510,000.00 |
Minority Stockholder's Interest |
36,137,307,000.00 |
Foreign Currency Capital |
-- |
Abnormal Management Project Income Adjusted |
-- |
Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
138,289,367,000.00 |
Owner's Equity(Stockholder's Equity) |
174,426,674,000.00 |
Total Liabilities and Owner's Equity(Stockholder's Equity) |
348,420,972,000.00 |